Pamela Coxson

InstitutionUniversity of California San Francisco
DepartmentEpidemiology & Biostatistics
Address550 16th. Street
San Francisco CA 94158
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Kazi DS, Penko J, Ollendorf DA, Coxson PG, Bibbins-Domingo K. Effect of Money-Back Guarantees on the Cost-Effectiveness of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors. Ann Intern Med. 2018 Apr 03. PMID: 29610832.
      View in: PubMed
    2. Huang C, Moran AE, Coxson PG, Yang X, Liu F, Cao J, Chen K, Wang M, He J, Goldman L, Zhao D, Kinney PL, Gu D. Potential Cardiovascular and Total Mortality Benefits of Air Pollution Control in Urban China. Circulation. 2017 Oct 24; 136(17):1575-1584. PMID: 28882886.
      View in: PubMed
    3. Kazi DS, Penko J, Coxson PG, Moran AE, Ollendorf DA, Tice JA, Bibbins-Domingo K. Updated Cost-effectiveness Analysis of PCSK9 Inhibitors Based on the Results of the FOURIER Trial. JAMA. 2017 08 22; 318(8):748-750. PMID: 28829863.
      View in: PubMed
    4. Heller DJ, Coxson PG, Penko J, Pletcher MJ, Goldman L, Odden MC, Kazi DS, Bibbins-Domingo K. Evaluating the Impact and Cost-Effectiveness of Statin Use Guidelines for Primary Prevention of Coronary Heart Disease and Stroke. Circulation. 2017 Sep 19; 136(12):1087-1098. PMID: 28687710.
      View in: PubMed
    5. Konfino J, Fernandez A, Penko J, Mason A, Martinez E, Coxson P, Heller D, Moran A, Bibbins-Domingo K, Pérez-Stable EJ, Mejía R. Comparing Strategies for Lipid Lowering in Argentina: An Analysis from the CVD Policy Model-Argentina. J Gen Intern Med. 2017 May; 32(5):524-533. PMID: 27853916.
      View in: PubMed
    6. Sánchez-Romero LM, Penko J, Coxson PG, Fernández A, Mason A, Moran AE, Ávila-Burgos L, Odden M, Barquera S, Bibbins-Domingo K. Projected Impact of Mexico's Sugar-Sweetened Beverage Tax Policy on Diabetes and Cardiovascular Disease: A Modeling Study. PLoS Med. 2016 Nov; 13(11):e1002158. PMID: 27802278.
      View in: PubMed
    7. Kazi DS, Moran AE, Coxson PG, Penko J, Ollendorf DA, Pearson SD, Tice JA, Guzman D, Bibbins-Domingo K. Cost-effectiveness of PCSK9 Inhibitor Therapy in Patients With Heterozygous Familial Hypercholesterolemia or Atherosclerotic Cardiovascular Disease. JAMA. 2016 Aug 16; 316(7):743-53. PMID: 27533159.
      View in: PubMed
    8. Moise N, Huang C, Rodgers A, Kohli-Lynch CN, Tzong KY, Coxson PG, Bibbins-Domingo K, Goldman L, Moran AE. Comparative Cost-Effectiveness of Conservative or Intensive Blood Pressure Treatment Guidelines in Adults Aged 35-74 Years: The Cardiovascular Disease Policy Model. Hypertension. 2016 07; 68(1):88-96. PMID: 27181996.
      View in: PubMed
    9. Vasudeva E, Moise N, Huang C, Mason A, Penko J, Goldman L, Coxson PG, Bibbins-Domingo K, Moran AE. Comparative Cost-Effectiveness of Hypertension Treatment in Non-Hispanic Blacks and Whites According to 2014 Guidelines: A Modeling Study. Am J Hypertens. 2016 Oct; 29(10):1195-205. PMID: 27172970; PMCID: PMC5018997 [Available on 10/01/17].
    10. Odden MC, Moran AE, Coxson PG, Peralta CA, Goldman L, Bibbins-Domingo K. Gait Speed as a Guide for Blood Pressure Targets in Older Adults: A Modeling Study. J Am Geriatr Soc. 2016 May; 64(5):1015-23. PMID: 27225357.
      View in: PubMed
    11. Wang M, Moran AE, Liu J, Coxson PG, Penko J, Goldman L, Bibbins-Domingo K, Zhao D. Projected Impact of Salt Restriction on Prevention of Cardiovascular Disease in China: A Modeling Study. PLoS One. 2016; 11(2):e0146820. PMID: 26840409; PMCID: PMC4739496.
    12. Gu D, He J, Coxson PG, Rasmussen PW, Huang C, Thanataveerat A, Tzong KY, Xiong J, Wang M, Zhao D, Goldman L, Moran AE. The Cost-Effectiveness of Low-Cost Essential Antihypertensive Medicines for Hypertension Control in China: A Modelling Study. PLoS Med. 2015 Aug; 12(8):e1001860. PMID: 26241895; PMCID: PMC4524696.
    13. Odden MC, Pletcher MJ, Coxson PG, Thekkethala D, Guzman D, Heller D, Goldman L, Bibbins-Domingo K. Cost-effectiveness and population impact of statins for primary prevention in adults aged 75 years or older in the United States. Ann Intern Med. 2015 Apr 21; 162(8):533-41. PMID: 25894023; PMCID: PMC4476404.
    14. Fontil V, Bibbins-Domingo K, Kazi DS, Sidney S, Coxson PG, Khanna R, Victor RG, Pletcher MJ. Simulating Strategies for Improving Control of Hypertension Among Patients with Usual Source of Care in the United States: The Blood Pressure Control Model. J Gen Intern Med. 2015 Aug; 30(8):1147-55. PMID: 25749880; PMCID: PMC4510247.
    15. Moran AE, Odden MC, Thanataveerat A, Tzong KY, Rasmussen PW, Guzman D, Williams L, Bibbins-Domingo K, Coxson PG, Goldman L. Cost-effectiveness of hypertension therapy according to 2014 guidelines. N Engl J Med. 2015 Jan 29; 372(5):447-55. PMID: 25629742; PMCID: PMC4403858.
    16. Wang M, Moran AE, Liu J, Coxson PG, Heidenreich PA, Gu D, He J, Goldman L, Zhao D. Cost-effectiveness of optimal use of acute myocardial infarction treatments and impact on coronary heart disease mortality in China. Circ Cardiovasc Qual Outcomes. 2014 Jan; 7(1):78-85. PMID: 24425706; PMCID: PMC4191653.
    17. Mekonnen TA, Odden MC, Coxson PG, Guzman D, Lightwood J, Wang YC, Bibbins-Domingo K. Health benefits of reducing sugar-sweetened beverage intake in high risk populations of California: results from the cardiovascular disease (CVD) policy model. PLoS One. 2013; 8(12):e81723. PMID: 24349119; PMCID: PMC3859539.
    18. Konfino J, Mekonnen TA, Coxson PG, Ferrante D, Bibbins-Domingo K. Projected impact of a sodium consumption reduction initiative in Argentina: an analysis from the CVD policy model--Argentina. PLoS One. 2013; 8(9):e73824. PMID: 24040085; PMCID: PMC3767589.
    19. Coxson PG, Cook NR, Joffres M, Hong Y, Orenstein D, Schmidt SM, Bibbins-Domingo K. Mortality benefits from US population-wide reduction in sodium consumption: projections from 3 modeling approaches. Hypertension. 2013 Mar; 61(3):564-70. PMID: 23399718.
      View in: PubMed
    20. Konfino J, Ferrante D, Mejia R, Coxson P, Moran A, Goldman L, Pérez-Stable EJ. Impact on cardiovascular disease events of the implementation of Argentina's national tobacco control law. Tob Control. 2014 Mar; 23(2):e6. PMID: 23092886; PMCID: PMC4026283.
    21. Ferrante D, Konfino J, Mejía R, Coxson P, Moran A, Goldman L, Pérez-Stable EJ. [The cost-utility ratio of reducing salt intake and its impact on the incidence of cardiovascular disease in Argentina]. Rev Panam Salud Publica. 2012 Oct; 32(4):274-80. PMID: 23299288.
      View in: PubMed
    22. Chan F, Adamo S, Coxson P, Goldman L, Gu D, Zhao D, Chen CS, He J, Mara V, Moran A. Projected impact of urbanization on cardiovascular disease in China. Int J Public Health. 2012 Oct; 57(5):849-54. PMID: 22918518; PMCID: PMC3465962.
    23. Wang YC, Coxson P, Shen YM, Goldman L, Bibbins-Domingo K. A penny-per-ounce tax on sugar-sweetened beverages would cut health and cost burdens of diabetes. Health Aff (Millwood). 2012 Jan; 31(1):199-207. PMID: 22232111.
      View in: PubMed
    24. Galper BZ, Moran A, Coxson PG, Pletcher MJ, Heidenreich P, Lazar LD, Rodondi N, Wang YC, Goldman L. Using stress testing to guide primary prevention of coronary heart disease among intermediate-risk patients: a cost-effectiveness analysis. Circulation. 2012 Jan 17; 125(2):260-70. PMID: 22144567; PMCID: PMC3265963.
    25. Odden MC, Coxson PG, Moran A, Lightwood JM, Goldman L, Bibbins-Domingo K. The impact of the aging population on coronary heart disease in the United States. Am J Med. 2011 Sep; 124(9):827-33.e5. PMID: 21722862; PMCID: PMC3159777.
    26. Lazar LD, Pletcher MJ, Coxson PG, Bibbins-Domingo K, Goldman L. Cost-effectiveness of statin therapy for primary prevention in a low-cost statin era. Circulation. 2011 Jul 12; 124(2):146-53. PMID: 21709063.
      View in: PubMed
    27. Moran A, Degennaro V, Ferrante D, Coxson PG, Palmas W, Mejia R, Perez-Stable EJ, Goldman L. Coronary heart disease and stroke attributable to major risk factors is similar in Argentina and the United States: the Coronary Heart Disease Policy Model. Int J Cardiol. 2011 Aug 04; 150(3):332-7. PMID: 21550675; PMCID: PMC3139755.
    28. Victor RG, Ravenell JE, Freeman A, Leonard D, Bhat DG, Shafiq M, Knowles P, Storm JS, Adhikari E, Bibbins-Domingo K, Coxson PG, Pletcher MJ, Hannan P, Haley RW. Effectiveness of a barber-based intervention for improving hypertension control in black men: the BARBER-1 study: a cluster randomized trial. Arch Intern Med. 2011 Feb 28; 171(4):342-50. PMID: 20975012; PMCID: PMC3365537.
    29. Pletcher MJ, Coxson PG. Does age modify effectiveness of statin therapy in coronary artery disease? Ann Intern Med. 2010 Jun 15; 152(12):825; author reply 825-6. PMID: 20547915.
      View in: PubMed
    30. Moran A, Gu D, Zhao D, Coxson P, Wang YC, Chen CS, Liu J, Cheng J, Bibbins-Domingo K, Shen YM, He J, Goldman L. Future cardiovascular disease in china: markov model and risk factor scenario projections from the coronary heart disease policy model-china. Circ Cardiovasc Qual Outcomes. 2010 May; 3(3):243-52. PMID: 20442213; PMCID: PMC2937540.
    31. Bibbins-Domingo K, Chertow GM, Coxson PG, Moran A, Lightwood JM, Pletcher MJ, Goldman L. Projected effect of dietary salt reductions on future cardiovascular disease. N Engl J Med. 2010 Feb 18; 362(7):590-9. PMID: 20089957; PMCID: PMC3066566.
    32. Lightwood J, Bibbins-Domingo K, Coxson P, Wang YC, Williams L, Goldman L. Forecasting the future economic burden of current adolescent overweight: an estimate of the coronary heart disease policy model. Am J Public Health. 2009 Dec; 99(12):2230-7. PMID: 19833999; PMCID: PMC2775763.
    33. Pletcher MJ, Lazar L, Bibbins-Domingo K, Moran A, Rodondi N, Coxson P, Lightwood J, Williams L, Goldman L. Comparing impact and cost-effectiveness of primary prevention strategies for lipid-lowering. Ann Intern Med. 2009 Feb 17; 150(4):243-54. PMID: 19221376.
      View in: PubMed
    34. Lightwood JM, Coxson PG, Bibbins-Domingo K, Williams LW, Goldman L. Coronary heart disease attributable to passive smoking: CHD Policy Model. Am J Prev Med. 2009 Jan; 36(1):13-20. PMID: 19095162; PMCID: PMC3940697.
    35. Moran A, Zhao D, Gu D, Coxson P, Chen CS, Cheng J, Liu J, He J, Goldman L. The future impact of population growth and aging on coronary heart disease in China: projections from the Coronary Heart Disease Policy Model-China. BMC Public Health. 2008 Nov 27; 8:394. PMID: 19036167; PMCID: PMC2631484.
    36. Bibbins-Domingo K, Coxson P, Pletcher MJ, Lightwood J, Goldman L. Adolescent overweight and future adult coronary heart disease. N Engl J Med. 2007 Dec 06; 357(23):2371-9. PMID: 18057339.
      View in: PubMed
    37. Gaspoz JM, Coxson PG, Goldman PA, Williams LW, Kuntz KM, Hunink MG, Goldman L. Cost effectiveness of aspirin, clopidogrel, or both for secondary prevention of coronary heart disease. N Engl J Med. 2002 Jun 06; 346(23):1800-6. PMID: 12050341.
      View in: PubMed
    38. Goldman L, Phillips KA, Coxson P, Goldman PA, Williams L, Hunink MG, Weinstein MC. The effect of risk factor reductions between 1981 and 1990 on coronary heart disease incidence, prevalence, mortality and cost. J Am Coll Cardiol. 2001 Oct; 38(4):1012-7. PMID: 11583874.
      View in: PubMed
    39. Tice JA, Ross E, Coxson PG, Rosenberg I, Weinstein MC, Hunink MG, Goldman PA, Williams L, Goldman L. Cost-effectiveness of vitamin therapy to lower plasma homocysteine levels for the prevention of coronary heart disease: effect of grain fortification and beyond. JAMA. 2001 Aug 22-29; 286(8):936-43. PMID: 11509058.
      View in: PubMed
    40. Phillips KA, Shlipak MG, Coxson P, Heidenreich PA, Hunink MG, Goldman PA, Williams LW, Weinstein MC, Goldman L. Health and economic benefits of increased beta-blocker use following myocardial infarction. JAMA. 2000 Dec 06; 284(21):2748-54. PMID: 11105180.
      View in: PubMed
    41. Goldman L, Coxson P, Hunink MG, Goldman PA, Tosteson AN, Mittleman M, Williams L, Weinstein MC. The relative influence of secondary versus primary prevention using the National Cholesterol Education Program Adult Treatment Panel II guidelines. J Am Coll Cardiol. 1999 Sep; 34(3):768-76. PMID: 10483959.
      View in: PubMed
    42. Weinstein MC, Coxson PG, Williams LW, Pass TM, Stason WB, Goldman L. Forecasting coronary heart disease incidence, mortality, and cost: the Coronary Heart Disease Policy Model. Am J Public Health. 1987 Nov; 77(11):1417-26. PMID: 3661794; PMCID: PMC1647098.